AnaptysBio ANAB
$46.63 −$0.77 (-1.62%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.63 0.00%
Open$47.49
Prev close$47.40
Day range$46.05 – $47.71
Volume432.5K
Market cap$1.39B
P/E (TTM)9.0
Dividend yield–
ANAB Stock News
Headlines matching AnaptysBio or the ANAB ticker, most recent first.
- J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $60 Negative
- Barclays Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75
- Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $81
- UBS Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $76
- TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating
- TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $70 Negative
- Piper Sandler Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $93
- TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75
- H.C. Wainwright Initiates AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $95
- Piper Sandler Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $93 Negative
- Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating
- J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $70 Positive
- Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $90 Positive
- A Quick Look at Today's Ratings for AnaptysBio(ANAB.US), With a Forecast Between $75 to $93
- UBS Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $76 Positive
No comments yet — be the first to weigh in on ANAB.
Sign in to join the discussion.